These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5556195)

  • 21. [Pharmacokinetics and metabolism of the cephalosporins].
    Graninger W
    Wien Klin Wochenschr Suppl; 1983; 142():11-5. PubMed ID: 6580781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dosage of Cefoperazone in Normal and Restricted Renal Function (author's transl].
    Piper C; Koeppe P; Höffler D
    MMW Munch Med Wochenschr; 1982 Mar; 124(10):244-8. PubMed ID: 6211612
    [No Abstract]   [Full Text] [Related]  

  • 23. Cefazolin plasma concentrations and urinary excretion in patients with renal impairment.
    Czerwinski AW; Pederson JA; Barry JP
    J Clin Pharmacol; 1974 Oct; 14(10):560-6. PubMed ID: 4430733
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacokinetics of Cefazedon, a new cephalosporin antibiotic, in patients with normal and reduced kidney function].
    Zimmermann G; Bauer U; Fuchs T; Kelleter H; Dingeldein E; Pabst J
    Med Welt; 1979 Jun; 30(22):868-72. PubMed ID: 440075
    [No Abstract]   [Full Text] [Related]  

  • 25. Cephradine absorption and excretion in fasting and nonfasting volunteers.
    Harvengt C; De Schepper P; Lamy F; Hansen J
    J Clin Pharmacol New Drugs; 1973 Jan; 13(1):36-40. PubMed ID: 4629988
    [No Abstract]   [Full Text] [Related]  

  • 26. Cephalexin: in vitro bacterial susceptibility, absorption in volunteers, and antibacterial activity of sera and urine.
    Perkins RL; Carlisle HN; Saslaw S
    Am J Med Sci; 1968 Aug; 256(2):122-9. PubMed ID: 5672745
    [No Abstract]   [Full Text] [Related]  

  • 27. Controlled assessment of the concentrations of a new cephalosporin in bile and gallbladder.
    Vittorini C; Vacca U; Foresta P; Corsi M; Longo P
    Arzneimittelforschung; 1981; 31(7):1163-5. PubMed ID: 7196766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cephradine.
    Drug Ther Bull; 1973 Jun; 11(12):47. PubMed ID: 4728211
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of therapeutic activity, of the secondary effects of blood and urinary levels of cephaloglycin by oral administration].
    Escárzaga Tapia E; Luna Castro M; González Díaz S; Gutiérrez Dávila M; Horta Sánchez C; Lozada L
    Rev Invest Clin; 1969; 21(1):35-47. PubMed ID: 5386523
    [No Abstract]   [Full Text] [Related]  

  • 30. Accumulation and excretion of middle molecules.
    Asaba H
    Clin Nephrol; 1983 Mar; 19(3):116-23. PubMed ID: 6839560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
    Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
    Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of low dose sulfadiazine in patients with renal failure.
    Seppänen J; Viranta M; Julkunen R; Wilén G
    Ann Clin Res; 1980; (25):31-7. PubMed ID: 7377747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients.
    Fillastre JP; Leroy A; Godin M; Oksenhendler G; Humbert G
    J Antimicrob Chemother; 1978 Jul; 4(B):79-83. PubMed ID: 690027
    [No Abstract]   [Full Text] [Related]  

  • 35. [Some parameters of platelet activation in patients with uremia before and after hemodialysis (HD)].
    Dymicka-Piekarska V; Matowicka-Karna J; Mantur M; Kemona H; Piszka J
    Przegl Lek; 2002; 59(12):980-3. PubMed ID: 12731371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics and tolerance of Cefazedone compared with Cefazoline (author's transl)].
    Hitzenberger G; Jaschek I
    Wien Med Wochenschr; 1980 Feb; 130(3):135-42. PubMed ID: 7368759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood, urine and tissue concentrations of the cephalosporin antibiotics in normal subjects.
    Griffith RS; Black HR
    Postgrad Med J; 1971 Feb; 47():Suppl:32-40. PubMed ID: 5556188
    [No Abstract]   [Full Text] [Related]  

  • 38. A pharmacokinetic comparison of cefadroxil and cephalexin after administration of 250, 500 and 1000 mg solution doses.
    Barbhaiya RH
    Biopharm Drug Dispos; 1996 May; 17(4):319-30. PubMed ID: 8743403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cephazoline: evolution of serum levels following the extent of renal functional disturbance. Comparison with other cephalosporins].
    Duval J; Lagrue G; Soussy CJ; Debain P
    Nouv Presse Med; 1974 Apr; 3(0):20-22. PubMed ID: 4837111
    [No Abstract]   [Full Text] [Related]  

  • 40. [The pharmacokinetics of antibiotics. II: Distribution of cephalosporins in the oral tissues of rats].
    Kawasaki Y; Nojima S
    Hiroshima Daigaku Shigaku Zasshi; 1982; 14(2):175-85. PubMed ID: 6963294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.